InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Explore the full record of transactions filed by Tatsis Ourania, Vice-Président Exécutif. Officer active across 1 companies, notably Vertex Pharmaceuticals INC / MA. Cumulatively, 6 filings have been published. Total volume traded: €635k. The latest transaction was disclosed on 17 March 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
€635,1232,799 shares@ €226.91070.0006% mcap28.2% of flow
Common Stock
SEC:0000899243-22-011705:0·
€522,0002,590 shares@ €201.54450.0005% mcap23.2% of flow
Common Stock
SEC:0000899243-22-008123:0·
€840,9004,114 shares@ €204.39950.0008% mcap37.3% of flow
Common Stock
SEC:0000899243-22-007216:0·
€256,0261,230 shares@ €208.15090.0002% mcap11.4% of flow
Common Stock
SEC:0001209191-22-009249:0·
03,500 shares0
Common Stock
SEC:0001209191-22-006794·
03,500 shares0
Common Stock
SEC:0001209191-22-006794:0·
6 of 6 declarations
About Tatsis Ourania
Tatsis Ourania is Executive Vice President and Chief Regulatory & Quality Officer at VERTEX PHARMACEUTICALS INC / MA. In this role, she oversees regulatory compliance and quality initiatives, ensuring that the company meets industry standards.
